Proscia announced the release of DermAI, which leverages deep learning to pre-screen and classify skin biopsies. Proscia’s software can automatically classify hundreds of variants of skin diseases into pre-diagnostic categories to improve the confidence, quality and speed of pathology. Using artificial intelligence, the software could help reduce costly errors and improve laboratory quality and efficiency. Read more about Proscia’s DermAI application here:
Featured Story:
Latest Articles
October 1, 2024